Holen Sie sich die Stockscreener-App
2.22
13.27%
0.26
Finanzdaten der Immix Biopharma Inc-Aktie (IMMX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
43.45%
6.7177
|
4.6829 | 4.9871 | 7.3949 | 4.7025 |
| Operating Income/Loss |
43.45%
-6.7177
|
-4.6829 | -4.9871 | -7.3949 | -4.7025 |
| Nonoperating Income/Loss |
30.73%
0.1041
|
0.1502 | 0.1859 | 0.2567 | 0.3069 |
| Income/Loss From Continuing Operations Before Tax |
45.91%
-6.6136
|
-4.5327 | -4.8013 | -7.1383 | -4.3956 |
| Income Tax Expense/Benefit |
9.24%
0.00891
|
0.00982 | 0.0108 | 0.0111 | 0.0103 |
| Income/Loss From Continuing Operations After Tax |
45.79%
-6.6226
|
-4.5425 | -4.8121 | -7.1494 | -4.4059 |
|
Net Income/Loss
|
45.79%
-6.6226
|
-4.5425 | -4.8121 | -7.1494 | -4.4059 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | -0.0129 |
| Basic Average Shares |
0.95%
29.98
|
29.70 | 0.4261 | 29.42 | 28.79 |
| Diluted Average Shares |
0.95%
29.98
|
29.70 | 0.4261 | 29.42 | 28.79 |
| Basic Earnings Per Share |
46.67%
-0.22
|
-0.15 | -0.16 | -0.24 | -0.15 |
| Diluted Earnings Per Share |
46.67%
-0.22
|
-0.15 | -0.16 | -0.24 | -0.15 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.19%
0.61%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):